BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10388474)

  • 21. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
    Eastham JA; May R; Robertson JL; Sartor O; Kattan MW
    Urology; 1999 Oct; 54(4):709-13. PubMed ID: 10510933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
    Cao XL; Gao JP; Han G; Tang J; Hong BF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final results of a screening campaign for prostate cancer.
    Martín E; Luján M; Sánchez E; Herrero A; Páez A; Berenguer A
    Eur Urol; 1999 Jan; 35(1):26-31. PubMed ID: 9933791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen.
    Stenman UH; Leinonen J; Zhang WM; Finne P
    Semin Cancer Biol; 1999 Apr; 9(2):83-93. PubMed ID: 10202130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic accuracy of digital rectal examination, transrectal ultrasonography, prostate-specific antigen (PSA) and PSA density in prostate carcinoma.
    Akdas A; Tarcan T; Türkeri L; Cevik I; Biren T; Gürmen N
    Br J Urol; 1995 Jul; 76(1):54-6. PubMed ID: 7544205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council.
    Crawford ED; DeAntoni EP; Etzioni R; Schaefer VC; Olson RM; Ross CA
    Urology; 1996 Jun; 47(6):863-9. PubMed ID: 8677578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
    Catalona WJ; Partin AW; Finlay JA; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL
    Urology; 1999 Aug; 54(2):220-4. PubMed ID: 10443714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
    Bangma CH; Rietbergen JB; Kranse R; Blijenberg BG; Petterson K; Schröder FH
    J Urol; 1997 Jun; 157(6):2191-6. PubMed ID: 9146612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen.
    Lechevallier E; Eghazarian C; Ortega JC; Roux F; Coulange C
    Urology; 1999 Nov; 54(5):857-61. PubMed ID: 10565747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An artificial neural network to predict the outcome of repeat prostate biopsies.
    Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
    Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.